Outcome of Patients with Preformed Donor-Specific Antibodies Following Alemtuzumab Induction and Tacrolimus Monotherapy

Outcome of Patients with Preformed Donor-Specific Antibodies Following Alemtuzumab Induction and Tacrolimus Monotherapy

It has been shown that low-level preformed donor-specific antibodies (DSAbs) detected by luminex beads in the setting of a negative CDC and flow cytometry crossmatch (CDC/FCXM) are associated with inferior allograft outcomes. The relevance of preformed DSAbs in patients receiving alemtuzumab inducti...

Full description

Saved in:
Bibliographic Details
Main Authors: Michelle Willicombe, Paul Brookes, Eva Santos‐Nunez, Jack Galliford, A. Ballow, A. McLean, Candice Roufosse, H. Terence Cook, Anthony Dorling, Anthony Ν. Warrens, Tom Cairns, David Taube
Format: Artigo
Language:English
Published: 2011
Online Access:https://doi.org/10.1111/j.1600-6143.2010.03421.x
http://www.amjtransplant.org/article/S1600613522278496/pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/j.1600-6143.2010.03421.x
http://www.amjtransplant.org/article/S1600613522278496/pdf

Similar Items